nach oben

Erschienen in:

2021 | OriginalPaper | Buchkapitel

11. Trockenes Auge/Sjögren-Syndrom (engl. Dry Eye Syndrome)

verfasst von : Elisabeth Messmer

Erschienen in: Entzündliche Augenerkrankungen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

ICD-10-Code M35.0 Sicca-Syndrom (Sjögren-Syndrom), H04.1 Keratoconjunctivitis sicca

Akpek EK, Bunya VY, Saldanha IJ (2019) Sjogren‘s Syndrome: More Than Just Dry Eye. Cornea 38:658–661

Akpek EK, Lindsley KB, Adyanthaya RS, Swamy R, Baer AN, McDonnell PJ (2011) Treatment of Sjogren’s syndrome-associated dry eye an evidence-based review. Ophthalmology 118(7):1242–1252. https://doi.org/10.1016/j.ophtha.2010.12.016CrossRefPubMed

Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA (2006) Epidemiology of primary Sjogren’s syndrome in north-west Greece, 1982–2003. Rheumatology 45(2):187–191. https://doi.org/10.1093/rheumatology/kei107CrossRefPubMed

Asbell PA, Maguire MG, Pistilli M et al (2018) n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. The New England journal of medicine 378:1681–1690

Baldini C, Luciano N, Tarantini G et al (2015) Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjogren‘s syndrome. Arthritis research & therapy 17:146

Barabino S, Rolando M, Camicione P, Ravera G, Zanardi S, Giuffrida S, Calabria G (2003) Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 22(2):97–101PubMedCrossRef

Baudouin C, Aragona P, Messmer EM et al (2013) Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. The ocular surface 11:246–258

Beckman KA, Luchs J, Milner MS, Ambrus JL Jr (2017) The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjogren‘s Syndrome Diagnosis. Advances in therapy 34:799–812

Bjerrum KB (1997) Keratoconjunctivitis sicca and primary Sjogren‘s syndrome in a Danish population aged 30-60 years. Acta ophthalmologica Scandinavica 75:281–286

Bolstad AI, Eiken HG, Rosenlund B, Alarcon-Riquelme ME, Jonsson R (2003) Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjogren’s syndrome. Arthritis Rheum 48(1):174–185. https://doi.org/10.1002/art.10734CrossRefPubMed

Bombardieri M, Baldini C, Alevizos I, Akpek E, Baer AN (2018) Highlights of the 14th International Symposium in Sjogren‘s Syndrome. Clinical and experimental rheumatology 36(Suppl 112):3–13

Bron AJ, de Paiva CS, Chauhan SK et al (2017) TFOS DEWS II pathophysiology report. The ocular surface 15:438–510PubMedCrossRef

Bunya VY, Bhosai SJ, Heidenreich AM et al (2016) Association of Dry Eye Tests With Extraocular Signs Among 3514 Participants in the Sjogren‘s Syndrome International Registry. American journal of ophthalmology 172:87–93

Bunya VY, Ying GS, Maguire MG et al (2018) Prevalence of Novel Candidate Sjogren Syndrome Autoantibodies in the Dry Eye Assessment and Management (DREAM) Study. Cornea 37:1425–1430PubMedPubMedCentralCrossRef

Castro I, Sepulveda D, Cortes J, Quest AF, Barrera MJ, Bahamondes V, Aguilera S, Urzua U, Alliende C, Molina C, Gonzalez S, Hermoso MA, Leyton C, Gonzalez MJ (2013) Oral dryness in Sjogren’s syndrome patients. Not just a question of water. Autoimmun Rev 12(5):567–574. https://doi.org/10.1016/j.autrev.2012.10.018CrossRefPubMed

Callaghan R, Prabu A, Allan RB et al (2007) Direct healthcare costs and predictors of costs in patients with primary Sjogren‘s syndrome. Rheumatology (Oxford, England) 46:105–111

Cardigos J, Barcelos F, Carvalho H et al (2019) Tear Meniscus and Corneal Sub-basal Nerve Plexus Assessment in Primary Sjogren Syndrome and Sicca Syndrome Patients. Cornea 38:221–228PubMedCrossRef

Chan CC, Borovik A, Hofmann I, Gulliver E, Rocha G (2018) Validity and Reliability of a Novel Handheld Osmolarity System for Measurement of a National Institute of Standards Traceable Solution. Cornea 37:1169–1174PubMedPubMedCentralCrossRef

Craig JP, Nichols KK, Akpek EK et al (2017) TFOS DEWS II Definition and Classification Report. The ocular surface 15:276–283PubMedCrossRef

Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya JM (2012) HLA and Sjogren’s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 11(4):281–287. https://doi.org/10.1016/j.autrev.2011.10.002CrossRefPubMed

Cursiefen C, Jacobi C, Dietrich T, Kruse FE (2006) Current treatment for dry eye syndrome. Der Ophthalmologe. Z der Dtsch Ophthalmol Gesellschaft 103(1):18–24. https://doi.org/10.1007/s00347-005-1300-9CrossRef

de Paiva CS, Jones DB, Stern ME et al (2016) Altered Mucosal Microbiome Diversity and Disease Severity in Sjogren Syndrome. Scientific reports 6:23561PubMedPubMedCentralCrossRef

Deshmukh US, Nandula SR, Thimmalapura PR, Scindia YM, Bagavant H (2009) Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function. J Oral Pathol Med Int Assoc Oral Pathol Am Acad Oral Patholo 38(1):42–47. https://doi.org/10.1111/j.1600-0714.2008.00700.xCrossRef

Elkon KB, Gharavi AE, Hughes GR, Moutsoupoulos HM (1984) Autoantibodies in the sicca syndrome (primary Sjogren’s syndrome). Ann Rheum Dis 43(2):243–245PubMedPubMedCentralCrossRef

Epitropoulos AT, Goslin K, Bedi R, Blackie CA (2017)Meibomian gland dysfunction patients with novel Sjogren‘s syndrome biomarkers benefit significantly from a single vectored thermal pulsation procedure: a retrospective analysis. Clinical ophthalmology (Auckland, NZ) 11:701–706

Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC et al (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320(5):265–271. https://doi.org/10.1056/nejm198902023200501CrossRefPubMed

Everett S, Vishwanath S, Cavero V et al (2017) Analysis of novel Sjogren‘s syndrome autoantibodies in patients with dry eyes. BMC ophthalmology 17:20

Fernandez Castro M, Sanchez-Piedra C, Andreu JL, Martinez Taboada V, Olive A, Rosas J (2018) Factors associated with severe dry eye in primary Sjogren‘s syndrome diagnosed patients. Rheumatology international 38:1075–1082

Fisher BA, Jonsson R, Daniels T et al (2017) Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren‘s syndrome. Annals of the rheumatic diseases 76:1161–1168

Foulks GN, Bron AJ (2003) Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocular Surf 1(3):107–126CrossRef

Foulks GN, Borchman D, Yappert M, Kim SH, McKay JW (2010) Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations. Cornea 29(7):781–788. https://doi.org/10.1097/ICO.0b013e3181cda38fCrossRefPubMedPubMedCentral

Fox RI, Kang HI (1992) Pathogenesis of Sjogren’s syndrome. Rheum Dis Clin N Am 18(3):517–538CrossRef

Fox RI, Kang HI, Ando D, Abrams J, Pisa E (1994) Cytokine mRNA expression in salivary gland biopsies of Sjogren’s syndrome. J Immunol 152(11):5532–5539. (Baltimore, Md : 1950)PubMedCrossRef

Godin MR, Stinnett SS, Gupta PK (2018) Outcomes of Thermal Pulsation Treatment for Dry Eye Syndrome in Patients With Sjogren Disease. Cornea 37:1155–1158PubMedCrossRef

Gonzales JA, Chou A, Rose-Nussbaumer JR et al (2018) How Are Ocular Signs and Symptoms of Dry Eye Associated With Depression in Women With and Without Sjogren Syndrome? American journal of ophthalmology 191:42–48PubMedPubMedCentralCrossRef

Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren’s syndrome. J Clin Invest 109(1):59–68. https://doi.org/10.1172/jci14121CrossRefPubMedPubMedCentral

Guellec D, Cornec D, Jousse-Joulin S, Marhadour T, Marcorelles P, Pers JO, Saraux A, Devauchelle-Pensec V (2013) Diagnostic value of labial minor salivary gland biopsy for Sjogren’s syndrome: a systematic review. Autoimmun Rev 12(3):416–420. https://doi.org/10.1016/j.autrev.2012.08.001CrossRefPubMed

Guimaraes de Souza R, Yu Z, Stern ME, Pflugfelder SC, de Paiva CS (2018) Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 34:543–549CrossRef

Hansen A, Dorner T (2010) Current therapeutic options in Sjogren’s syndrome. Z Rheumatol 69(1):19–24. https://doi.org/10.1007/s00393-009-0515-6CrossRefPubMed

Hammenfors DS, Valim V, Bica B et al (2019) Juvenile Sjogren‘s syndrome: clinical characteristics with focus on salivary gland ultrasonography. Arthritis care & research

Haque RM, Torkildsen GL, Brubaker K, Zink RC, Kowalski RP, Mah FS, Pflugfelder SC (2010) Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1 % on the signs and symptoms of subjects with blepharitis. Cornea 29(8):871–877. https://doi.org/10.1097/ICO.0b013e3181ca38a0

Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15–25. https://doi.org/10.1002/art.23177CrossRefPubMed

Howlett DC, Menezes LJ, Lewis K, Moody AB, Violaris N, Williams MD (2007) Sonographically guided core biopsy of a parotid mass. AJR American journal of roentgenology 188:223–227PubMedCrossRef

Hwang JM, Lee JM, Chung Sh Md P (2019) Comparison of Meibomian Gland Imaging Findings and Lipid Layer Thickness between Primary Sjogren Syndrome and Non-Sjogren Syndrome Dry Eyes. Ocular immunology and inflammation:1–6

Jacobi C, Cursiefen C (2010) Ophthalmological complications in Sjogren’s syndrome. Z Rheumatol 69(1):32–40. https://doi.org/10.1007/s00393-009-0517-4CrossRefPubMed

Jacobi C, Jacobi A, Kruse FE, Cursiefen C (2011) Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea 30(12):1289–1292. https://doi.org/10.1097/ICO.0b013e31821de383CrossRefPubMed

James MJ, Gibson RA, Cleland LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71(1):343S–348SPubMedCrossRef

Jones L, Downie LE, Korb D et al (2017) TFOS DEWS II Management and Therapy Report. The ocular surface 15:575–628PubMedCrossRef

Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S (2011) The complexity of Sjogren’s syndrome: novel aspects on pathogenesis. Immunol Lett 141(1):1–9. https://doi.org/10.1016/j.imlet.2011.06.007CrossRefPubMed

Karakus S, Baer AN, Akpek EK (2019) Clinical Correlations of Novel Autoantibodies in Patients with Dry Eye. Journal of immunology research 2019:7935451PubMedPubMedCentralCrossRef

Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK (2000) Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 118(11):1489–1496PubMedCrossRef

Kuzin II, Snyder JE, Ugine GD, Wu D, Lee S, Bushnell T Jr, Insel RA, Young FM, Bottaro A (2001) Tetracyclines inhibit activated B cell function. Int Immunol 13(7):921–931PubMedCrossRef

Lai Z, Yin H, Cabrera-Perez J et al (2016) Aquaporin gene therapy corrects Sjogren‘s syndrome phenotype in mice. Proceedings of the National Academy of Sciences of the United States of America 113:5694–5699

Lanza NL, McClellan AL, Batawi H et al (2016) Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients. The ocular surface 14:216–223PubMedPubMedCentralCrossRef

Lemp MA, Bron AJ, Baudouin C, Del Benitez Castillo JM, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD (2011) Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 151(5):792–798. https://doi.org/10.1016/j.ajo.2010.10.032CrossRefPubMed

Leonardi A, Messmer EM, Labetoulle M et al (2019) Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies. The British journal of ophthalmology 103:125–131

Levy O, Labbe A, Borderie V et al (2017) Increased corneal sub-basal nerve density in patients with Sjogren syndrome treated with topical cyclosporine A. Clinical & experimental ophthalmology 45:455–463CrossRef

Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE (2010) Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocular Pharmacol Therapeutics J Assoc Ocular Pharmacol Therapeutics 26(5):431–439. https://doi.org/10.1089/jop.2010.0019CrossRef

Low HZ, Witte T (2011) Aspects of innate immunity in Sjogren’s syndrome. Arthritis research & therapy 13(3):218. https://doi.org/10.1186/ar3318CrossRef

Malet F, Le Goff M, Colin J et al (2014) Dry eye disease in French elderly subjects: the Alienor Study. Acta ophthalmologica 92:e429–e436PubMedCrossRef

Marsh P, Pflugfelder SC (1999) Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 106(4):811–816. https://doi.org/10.1016/s0161-6420(99)90171-9CrossRefPubMed

Matsuda S, Koyasu S (2000) Mechanisms of action of cyclosporine. Immunopharmacology 47(2–3):119–125PubMedCrossRef

McDonald M, Patel DA, Keith MS, Snedecor SJ (2016) Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review. The ocular surface 14:144–167PubMedCrossRef

Messmer EM, von Lindenfels V, Garbe A, Kampik A (2016) Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay. Ophthalmology 123:2300–2308PubMedCrossRef

Mofors J, Arkema EV, Bjork A et al (2019) Infections increase the risk of developing Sjogren‘s syndrome. Journal of internal medicine

Nguyen CQ, Peck AB (2009) Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocular Surf 7(1):11–27CrossRef

Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R (2004) A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5 %, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 138(3):444–457. https://doi.org/10.1016/j.ajo.2004.04.052

Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR (2008) Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 126(2):219–225. https://doi.org/10.1001/archophthalmol.2007.61CrossRefPubMed

Ricchiuti V, Isenberg D, Muller S (1994) HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjogren’s syndrome. J Autoimmun 7(5):611–621. https://doi.org/10.1006/jaut.1994.1045CrossRefPubMed

Rosen A, Casciola-Rosen L (2004) Altered autoantigen structure in Sjogren’s syndrome: implications for the pathogenesis of autoimmune tissue damage. Critical Rev Oral Biology Med Am Assoc Oral Biologists 15(3):156–164CrossRef

Sadrai Z, Hajrasouliha AR, Chauhan S, Saban DR, Dastjerdi MH, Dana R (2011) Effect of topical azithromycin on corneal innate immune responses. Invest Ophthalmol Vis Sci 52(5):2525–2531. https://doi.org/10.1167/iovs.10-5658CrossRefPubMedPubMedCentral

Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S (2008) Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 181(4):2898–2906. (Baltimore, Md : 1950)PubMedCrossRef

Sall K, Stevenson OD, Mundorf TK, Reis BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107(4):631–639PubMedCrossRef

Sambursky R, Davitt WF 3rd, Latkany R, Tauber S, Starr C, Friedberg M, Dirks MS, McDonald M (2013) Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA ophthalmology 131(1):24–28. https://doi.org/10.1001/jamaophthalmol.2013.561CrossRefPubMed

Sanchez-Avila RM, Merayo-Lloves J, Riestra AC et al (2017) The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjogren Syndrome. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 33:391–399CrossRef

Shah M, Edman MC, Reddy Janga S et al (2017) Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjogren‘s Syndrome. Investigative ophthalmology & visual science 58:372–385

Shiboski CH, Baer AN, Shiboski SC et al (2018) Natural History and Predictors of Progression to Sjogren‘s Syndrome Among Participants of the Sjogren‘s International Collaborative Clinical Alliance Registry. Arthritis care & research 70:284–294

Shiboski CH, Shiboski SC, Seror R et al (2016) American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren‘s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Annals of the rheumatic diseases 76:9–16

Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31(4):325–330. https://doi.org/10.1016/j.jaut.2008.08.004CrossRefPubMed

Stapleton F, Alves M, Bunya VY et al (2017) TFOS DEWS II Epidemiology Report. The ocular surface 15:334–365PubMedCrossRef

Solomon A, Rosenblatt M, Li DQ, Liu Z, Monroy D, Ji Z, Lokeshwar BL, Pflugfelder SC (2000) Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci 41(9):2544–2557PubMed

Sullivan DA (1997) Sex hormones and Sjogren’s syndrome. J Rheumatol Suppl 50:17–32PubMed

Sullivan DA, Dana R, Sullivan RM et al (2018) Meibomian Gland Dysfunction in Primary and Secondary Sjogren Syndrome. Ophthalmic research 59:193–205PubMedCrossRef

Sullivan RM, Cermak JM, Papas AS, Dana MR, Sullivan DA (2002) Economic and quality of life impact of dry eye symptoms in women with Sjogren’s syndrome. Adv Exp Med Biol 506:1183–1188PubMedCrossRef

Tai MC, Cosar CB, Cohen EJ, Rapuano CJ, Laibson PR (2002) The clinical efficacy of silicone punctal plug therapy. Cornea 21(2):135–139PubMedCrossRef

Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF (1990) Detection of serum antibodies to retroviral proteins in patients with primary Sjogren’s syndrome (autoimmune exocrinopathy). Arthritis Rheum 33(6):774–781PubMedCrossRef

The definition and classification of dry eye disease (2007) Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. The ocular surface 5:75–92

The definition and classification of dry eye disease (2017) report of the definition and classification subcommittee of the international dry eye workshop. Ocul Surf 5(2):75–92

Triantafyllopoulou A, Tapinos N, Moutsopoulos HM (2004) Evidence for coxsackievirus infection in primary Sjogren’s syndrome. Arthritis Rheum 50(9):2897–2902. https://doi.org/10.1002/art.20463CrossRefPubMed

Tong L, Beuerman R, Simonyi S, Hollander DA, Stern ME (2016) Effects of Punctal Occlusion on Clinical Signs and Symptoms and on Tear Cytokine Levels in Patients with Dry Eye. The ocular surface 14:233–241PubMedCrossRef

Turner K, Pflugfelder SC, Ji Z, Feuer WJ, Stern M, Reis BL (2000) Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea 19(4):492–496PubMedCrossRef

Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM (2018) Th17 cells in primary Sjogren‘s syndrome: Pathogenicity and plasticity. Journal of autoimmunity 87:16–25

Vinagre F, Santos MJ, Prata A, da Silva JC, Santos AI (2009) Assessment of salivary gland function in Sjogren’s syndrome: the role of salivary gland scintigraphy. Autoimmun Rev 8(8):672–676. https://doi.org/10.1016/j.autrev.2009.02.027CrossRefPubMed

Viso E, Rodriguez-Ares MT, Abelenda D, Oubina B, Gude F (2012) Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Investigative ophthalmology & visual science 53:2601–2606CrossRef

Viso E, Rodriguez-Ares MT, Gude F (2009) Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic epidemiology 16:15–21PubMedCrossRef

Vivino FB (2017) Sjogren‘s syndrome: Clinical aspects. Clinical immunology (Orlando, Fla) 182:48–54

Vivino FB, Gala I, Hermann GA (2002) Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. The Journal of rheumatology 29:938–944PubMed

Waterman SA, Gordon TP, Rischmueller M (2000) Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren’s syndrome. Arthritis Rheum 43(7):1647–1654. https://doi.org/10.1002/1529-0131(200007)43:7<1647::aid-anr31>3.0.co;2-CrossRefPubMed

Whitcher JP, Shiboski CH, Shiboski SC et al (2010) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren‘s Syndrome International Registry. American journal of ophthalmology 149:405–415

Witte T (2010) Pathogenesis and diagnosis of Sjogren’s syndrome. Z Rheumatol 69(1):50–56. https://doi.org/10.1007/s00393-009-0519-2CrossRefPubMed

Witte T, Matthias T, Oppermann M, Helmke K, Peter HH, Schmidt RE, Tishler M (2003) Prevalence of antibodies against alpha-fodrin in Sjogren’s syndrome: comparison of 2 sets of classification criteria. J Rheumatol 30(10):2157–2159PubMed

Wolffsohn JS, Arita R, Chalmers R et al (2017) TFOS DEWS II Diagnostic Methodology report. The ocular surface 15:539–574PubMedCrossRef

Yokogawa N, Lieberman SM, Sherry DD, Vivino FB (2016) Features of childhood Sjogren‘s syndrome in comparison to adult Sjogren‘s syndrome: considerations in establishing child-specific diagnostic criteria. Clinical and experimental rheumatology 34:343–351

Yokoi N, Kato H, Kinoshita S (2016) The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjogren‘s syndrome: a pilot study. Eye (London, England) 30:857–864

Yoon HJ, Choi W, Yang JM, Ji YS, Lee SS, Yoon KC (2019) Characteristics of dry eye in patients with pre-existing Sjogren‘s syndrome according to the revised 2016 ACR-EULAR classification criteria. Medicine 98:e14641

Yoshida A, Fujihara T, Nakata K (1999) Cyclosporin a increases tear fluid secretion via release of sensory neurotransmitters and muscarinic pathway in mice. Exp Eye Res 68(5):541–546. https://doi.org/10.1006/exer.1998.0619CrossRefPubMed

Youinou P, Pers JO (2011) Disturbance of cytokine networks in Sjogren’s syndrome. Arthritis Res Therapy 13(4):227. https://doi.org/10.1186/ar3348CrossRef

Yu J, Asche CV, Fairchild CJ (2011) The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea 30(4):379–387. https://doi.org/10.1097/ICO.0b013e3181f7f363CrossRefPubMed

Zaheer M, Wang C, Bian F et al (2018) Protective role of commensal bacteria in Sjogren Syndrome. Journal of autoimmunity 93:45–56PubMedPubMedCentralCrossRef

Zang S, Cui Y, Cui Y, Fei W (2018) Meibomian gland dropout in Sjogren‘s syndrome and non-Sjogren‘s dry eye patients. Eye (London, England) 32:1681–1687

Titel: Trockenes /Sjögren-Syndrom (engl. Dry Eye Syndrome)
verfasst von: Elisabeth Messmer
Verlag: Springer Berlin Heidelberg
Buch: Entzündliche Augenerkrankungen
Print ISBN: 978-3-662-60398-7

Electronic ISBN: 978-3-662-60399-4

Copyright-Jahr: 2021
DOI: https://doi.org/10.1007/978-3-662-60399-4_11

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

11. Trockenes Auge/Sjögren-Syndrom (engl. Dry Eye Syndrome)

Zusammenfassung

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde